Related Experiment Video
Updated: Aug 9, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Impact of Persistent Multidrug-Resistant Gram-Negative Bacteremia on Clinical Outcome and Mortality
Shiori Kitaya1,2, Hajime Kanamori1, Yukio Katori2
1Department of Infectious Diseases, Internal Medicine, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.
Abstract:
The clinical aspects of persistent bacteremia (PB) caused by gram-negative rods (GNRs) in terms of antimicrobial resistance (AMR) and PB clearance status are unclear. This secondary analysis of a retrospective cohort study investigated differences in PB caused by Enterobacterales and glucose non-fermentative GNRs (NF-GNRs) based on AMR and PB clearance. We retrospectively surveyed medical records at Tohoku University Hospital. Patients for whom blood cultures were performed between January 2012 and December 2021 were recruited. PB cases were grouped based on AMR and PB clearance; the characteristics of PB due to each bacterial pathogen were examined. The main outcome variable was mortality. The late (30-90-day) mortality rate was significantly higher in the multidrug-resistant (MDR) group than in the non-MDR group for Enterobacterales. However, no significant difference was noted in mortality rates between NF-GNRs with and without AMR. Mortality rates tended to be higher in the non-PB-clearance group than in the clearance group for both Enterobacterales and NF-GNRs. Since the mortality rate was higher in the MDR group in the case of Enterobacterales PB, more careful management is necessary for this condition. Follow-up blood cultures and confirming the clearance of PB are useful for improving the survival rate.
Insights
Persistent bacteremia (PB) from multidrug-resistant Enterobacterales significantly increases mortality. Clearing PB through follow-up blood cultures is crucial for improving survival rates in gram-negative rod infections.
Area of Science:
- Infectious Diseases
- Clinical Microbiology
- Antimicrobial Resistance
Background:
- Persistent bacteremia (PB) caused by gram-negative rods (GNRs) presents challenges regarding antimicrobial resistance (AMR) and clearance.
- Understanding the clinical impact of AMR and PB clearance is essential for patient outcomes.
Purpose of the Study:
- To investigate differences in PB caused by Enterobacterales and non-fermentative GNRs (NF-GNRs).
- To analyze the impact of AMR and PB clearance status on mortality.
Main Methods:
- Secondary analysis of a retrospective cohort study at Tohoku University Hospital (2012-2021).
- PB cases were categorized by AMR and clearance status.
- Mortality rates were compared between bacterial groups and resistance/clearance statuses.
Main Results:
- Late mortality was significantly higher in multidrug-resistant (MDR) Enterobacterales PB compared to non-MDR.
- No significant mortality difference was observed for NF-GNRs with or without AMR.
- Mortality rates were higher in the non-PB-clearance group for both Enterobacterales and NF-GNRs.
Conclusions:
- MDR Enterobacterales PB requires careful management due to increased mortality risk.
- Confirming PB clearance via follow-up blood cultures is vital for improving patient survival rates.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
07:30Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Development of Antibiotic Resistance
Antimicrobial Effectiveness
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment